Prevention of thrombus embolization during primary percutaneous intervention using a novel mesh covered stent

Ajay Jain1, Roshan Weerackody, Simon Kennon

  • 1Department of Cardiology, Bart's and The London NHS Trust, London, UK. martin.rothman@bartsandthelondon.nhs.uk

Insights

A novel mesh-covered stent effectively prevented embolization during percutaneous coronary intervention for patients with significant thrombus burden. This approach achieved optimal blood flow, reducing a common procedural complication.

Area of Science:

  • Interventional Cardiology
  • Biomedical Engineering
  • Vascular Surgery

Background:

  • Embolization of athero-thrombotic material is a frequent complication during primary percutaneous coronary intervention (PCI).
  • Existing methods like thrombus aspiration and distal protection aim to mitigate this risk.
  • Significant thrombus burden presents a particular challenge in PCI procedures.

Observation:

  • A novel mesh-covered stent was utilized in five cases of primary PCI involving coronary arteries with large thrombus volumes.
  • The stent's mesh covering is engineered to theoretically capture and retain embolic material, preventing distal migration.
  • The procedure involved intervention to coronary arteries with extensive athero-thrombotic material.

Findings:

  • The novel mesh-covered stent successfully ensnared thrombus in all five cases.
  • TIMI (Thrombolysis In Myocardial Infarction) grade III flow was achieved post-procedure in all patients.
  • The stent demonstrated efficacy in preventing distal embolization despite a high thrombus burden.

Implications:

  • This mesh-covered stent offers a promising new strategy for managing complex PCI cases with high thrombus burden.
  • It may reduce periprocedural complications associated with athero-thrombotic embolization.
  • Further research could validate its widespread use in interventional cardiology.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...